The maker of the EpiPen has raised the price of two injectable treatments to about $600, six times the price nine years ago. Why do drug companies do this? Because they can.
from Live Science http://ift.tt/2bRPtU0
via IFTTT
world and global knowledge that you should know
0 komentar:
Posting Komentar